[Sponsored] Make Biotech Showcase your homebase during the busiest week in healthcare. The event convenes 3,200 life science leaders, including 1,200+ investors and over 340 presenting companies, for three days of breakthrough innovation, investment opportunities and strategic collaborations.

The post Biotech Showcase™: Where Innovation Meets Investment and Partnerships appeared first on MedCity News.

[Sponsored] In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.

The post As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities appeared first on MedCity News.

Take part in our Reader Survey and help us continue to grow!

The post Do You Value MedCity News? Take Our Survey! appeared first on MedCity News.

[Sponsored] A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they’re advising startups in the wake of cuts to NIH and SBIR grants.

The post Get a Snapshot of the Early Stage Life Science Startup Landscape appeared first on MedCity News.

[Sponsored] Sign up today and and join us on May 8th where we’ll explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies.

The post Webinar: How Fintech Can Accelerate Growth for Early-Stage Life Science Companies appeared first on MedCity News.

[Sponsored] A webinar on May 8th will explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies.

The post How Can Fintech Make it Easier for Early Stage Life Science Companies to Grow? appeared first on MedCity News.

The way ahead for HEOR in biopharma should be built on increasing C-suite visibility and understanding of the value contribution that HEOR makes and demonstrating that a failure to invest in HEOR puts companies at a competitive disadvantage, especially in the face of rising regulatory and payer expectations for evidence.

The post Health Economics and Outcomes Research: Biopharma’s Underappreciated Value Creator appeared first on MedCity News.

The “holy grail” of ATMP-based treatments is to provide cures for some of the world’s most debilitating disease states, but for this to occur, a unified front is needed to democratize these therapies – collaboration from industry, academia, supply chain and, indeed, clinicians and hospitals is paramount to ensuring safe manufacturing and transit.

The post Vitality in the Supply Chain: The Limitless Potential of ATMPs appeared first on MedCity News.

[Sponsored] Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug’s effect on the body, and more.

The post 4 Ways Biopharma Is Applying AI/ML to Improve Drug Development Outcomes appeared first on MedCity News.

[Sponsored] Anita Nelsen, Senior Vice President of Clinical Trial Operations at Allucent, shares her insights on how to navigate the drug development landscape.

The post Why Effective and Efficient Clinical Trial Operations Are More Complex and More Important than Ever in a Post-Pandemic World appeared first on MedCity News.

In the runup to INVEST and the startup pitch contest, we highlight trends in investment and innovation across bipharma, diagnostics, medical devices, health tech: payer/provider, and health tech: consumer/employer. The deadline has been extended until February 28 and finalists will be announced March 31. Apply today!

The post Apply to MedCity INVEST Pitch Perfect Where Investment Trends and Innovation Converge appeared first on MedCity News.

With five tracks of startups across healthcare and life sciences, INVEST Pitch Perfect, scheduled for May 22-24 at the Ritz Carlton in Chicago, is MedCity’s largest startup pitch contest of the year. 

The post Time Is Running Out to Apply for MedCity’s Largest Pitch Contest of the Year appeared first on MedCity News.

Maina Bhaman, a board member of CinCor Pharma reflects on the news from Monday that AstraZeneca is acquiring the Massachusetts startup to bring another option for patients with resistant hypertension.

The post A VC’s take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca appeared first on MedCity News.

[Sponsored] The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: Their learning and development programs.

The post How L&D in Regulated Industries Can Move Beyond Just Compliance to Impact appeared first on MedCity News.

Read about executive hires across healthcare and life sciences.

The post Healthcare Hires of Note appeared first on MedCity News.

A former Theranos lab director who testified during Elizabeth Holmes’ trial said he’s had trouble sleeping because of regrets about the trial and showed up at her door “disheveled” and wanting to talk.

The post Elizabeth Holmes requests new trial after “star witness” expresses regrets appeared first on MedCity News.

[Sponsored] In a recent interview, Jennifer Cubino, COO of BC Platforms, discussed regulatory differences between the U.S., the European Union and other countries amid ongoing efforts to encourage patients who want to share their data.

The post Putting patients at the center of RWD collection processes appeared first on MedCity News.

[Sponsored] Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.

The post How the agile in pharma trend is transforming drug development appeared first on MedCity News.

[Sponsored] The French delegation at BIO on June 13-16 has a compelling story to tell about biopharma and medtech growth and investment in France and the U.S. Here’s a preview of some of the companies that will be at the convention, events they will host and why you should check them out.

The post At BIO, French delegation highlights its plans for healthcare and biotech development appeared first on MedCity News.

Founded in 2021, Gandeeva is developing precision imaging solutions with the integration of cryo-electron microscopy (cryo-EM) and artificial intelligence. Its technology can be applied to advance drug discovery and by lowering risks of late-stage clinical failures.

The post Gandeeva CEO shares how integrating AI with cryo-electron microscopy can support drug discovery appeared first on MedCity News.

MedCity INVEST PharmaTech, a virtual conference scheduled for July 26, will bring together technology disruptors, Big Pharma and biotech leaders, investors and entrepreneurs to discuss how to adopt digital strategies to transform every aspect of the pharma industry.

The post INVEST PharmaTech: The convergence of digital health and biopharma appeared first on MedCity News.

AnHeart Therapeutics is developing a pipeline of precision oncology therapeutics. Chief Business Officer and Co-founder Lihua Zheng provided an overview of company’s strategy in response to emailed questions.

The post Precision oncology startup AnHeart Therapeutics co-founder shares cancer drug strategy appeared first on MedCity News.

Check out new developments from DNA Script, DermBiont, Healthmine, and more.

The post StartUPDATES: New developments from healthcare startups appeared first on MedCity News.

[Sponsored] In order to benefit from the Virtual1Care trend, pharma and medtech companies must ensure that their digital health tools, wrapped around a drug or device, comply with evolving regulations.

The post BrightInsight CEO Kal Patel M.D. discusses the future of regulated digital health for biopharma and medtech  appeared first on MedCity News.

[Sponsored] Microsoft seeks to change the way pharma industry companies use technology to navigate human resource challenges and restore confidence in drug development supply chains.

The post Remote service: The new paradigm for biopharma manufacturing appeared first on MedCity News.

[Sponsored] The webinar on November 18th at 1pm ETwill address considerations around building a personalized connected care solution and how you can achieve it in a very short timeframe.

The post BioT webinar will explore personalized approach to connected care appeared first on MedCity News.

Check out news from Healthmine, Marley Medical, Alloy, Culture Biosciences and more.

The post StartUPDATES: New developments from healthcare startups appeared first on MedCity News.

[Sponsored] Which capital funding options fit your healthcare or life science business?

The post Navigating the life science and healthcare funding landscape appeared first on MedCity News.

The death occurred less than two weeks after Astellas Pharma reported that the patient developed liver problems after being dosed with the experimental gene therapy for a rare neuromuscular disorder. Astellas said the cause of death is still under investigation, and the FDA has placed a clinical hold on the study.

The post Astellas Pharma reports fourth patient death in gene therapy clinical trial appeared first on MedCity News.

Each Organ-Chip is a transparent, flexible microenvironment that contains two parallel chambers that can be configured to grow human cells from an organ of interest, such as the liver, kidney proximal tubule, intestine, lung and brain

The post Emulate CEO shares the organ-chip maker’s vision to understand and predict drug response appeared first on MedCity News.